Literature DB >> 12781715

A functional interferon regulatory factor-1 (IRF-1)-binding site in the upstream regulatory region (URR) of human papillomavirus type 16.

Istvan Arany1, Kenneth J Grattendick, William E Whitehead, Istvan A Ember, Stephen K Tyring.   

Abstract

We recently identified a new enhancer element (HIRE-1, HPV-Interferon Responsive Element-1) in the upstream regulatory region (URR) of human papillomavirus (HPV) type 16. HIRE-1 is located upstream from and in close proximity to the TATA box. HIRE-1 is 1 nt shorter in its 5' sequence in comparison to a consensus IRF-1 binding site (IRF-E). Gel shift analyses clearly demonstrated that HIRE-1 is capable of binding IRF-1 in response to interferon-gamma (IFN-gamma) treatment. In a reporter system, HIRE-1 stimulated transcription in response to IRF-1 or IFN gamma from both a heterologous or the homologous (p97) promoter in a dose-dependent manner. Mutations in the core binding sequence strongly decreased this enhancer activity. Interestingly, HIRE-1 stimulated transcription in the context of the full URR in a cell-type-specific manner, thereby suggesting the role of other cell-type-specific factors that might counteract with its function. Thus, our results may explain the inconsistent clinical and experimental results observed following IFN treatment of cervical lesions or cells. Also, this new enhancer may have an important function during inflammatory responses against HPV type 16.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12781715     DOI: 10.1016/s0042-6822(03)00138-7

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  8 in total

1.  Expression and DNA binding activity of the recombinant interferon regulatory factor-1 (IRF-1) of mouse.

Authors:  Meenakshi Upreti; Pramod C Rath
Journal:  Mol Biol Rep       Date:  2005-06       Impact factor: 2.316

2.  Functional mapping of the human papillomavirus type 16 E1 cistron.

Authors:  Michael J Lace; James R Anson; Lubomir P Turek; Thomas H Haugen
Journal:  J Virol       Date:  2008-08-27       Impact factor: 5.103

3.  Leukemia inhibitory factor downregulates human papillomavirus-16 oncogene expression and inhibits the proliferation of cervical carcinoma cells.

Authors:  Joseph M Bay; Bruce K Patterson; Nelson N H Teng
Journal:  Infect Dis Obstet Gynecol       Date:  2011-06-04

4.  A temporal gate for viral enhancers to co-opt Toll-like-receptor transcriptional activation pathways upon acute infection.

Authors:  Kai A Kropp; Wei Yuan Hsieh; Elena Isern; Thorsten Forster; Eva Krause; Wolfram Brune; Ana Angulo; Peter Ghazal
Journal:  PLoS Pathog       Date:  2015-04-09       Impact factor: 6.823

Review 5.  Biological and clinical basis for molecular studies of interferons.

Authors:  Katie R Pang; Jashin J Wu; David B Huang; Stephen K Tyring; Samuel Baron
Journal:  Methods Mol Med       Date:  2005

Review 6.  Endogenous retrovirus-K promoter: a landing strip for inflammatory transcription factors?

Authors:  Mamneet Manghera; Renée N Douville
Journal:  Retrovirology       Date:  2013-02-09       Impact factor: 4.602

7.  Smoking enhances risk for new external genital warts in men.

Authors:  Dorothy J Wiley; David Elashoff; Emmanuel V Masongsong; Diane M Harper; Karen H Gylys; Michael J Silverberg; Robert L Cook; Lisette M Johnson-Hill
Journal:  Int J Environ Res Public Health       Date:  2009-03-20       Impact factor: 3.390

8.  Interferon-beta treatment increases human papillomavirus early gene transcription and viral plasmid genome replication by activating interferon regulatory factor (IRF)-1.

Authors:  Michael J Lace; James R Anson; Aloysius J Klingelhutz; Hisashi Harada; Tadatsugu Taniguchi; Aaron D Bossler; Thomas H Haugen; Lubomir P Turek
Journal:  Carcinogenesis       Date:  2009-06-18       Impact factor: 4.944

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.